With the primary objective of protecting the health of the Venezuelan people amid the COVID-19 pandemic, Venezuela received on Thursday the first batch of Abdala vaccines, developed by Cuba, to move forward with the mass vaccination campaign.
With this first batch, the Bolivarian nation becomes the world’s first country to receive the Abdala vaccine.
Noteworthily, Venezuela participated in April this year in the third phase of clinical trials of this vaccine, which has shown a 92% efficacy.
Abdala is one of the five candidates developed by Cuba’s biopharmaceutical industry as an important contribution to the fight against COVID-19, proving again the Caribbean country’s solidarity and commitment to health despite the obstacles it faces.
Venezuela received this first shipment of Cuban vaccines on the commemoration of the Bicentennial of the Battle of Carabobo, a heroic deed that sealed the South American country’s independence. Also, the 19th Summit of Heads of State and Government of the Bolivarian Alliance for the Peoples of Our America-People’s Trade Treaty (ALBA-TCP) is taking place in Caracas on this day.